This content is 10 years old. Content may be out of date.

Demand for malaria drug soars

WWARN Published Date

Farmers and scientists struggle to keep up with needs of ambitious medicine-subsidy programme.

From bust to boom to bust again: artemisinin, the key ingredient of front-line antimalarial drugs, is entering the third chapter of its turbulent history, reports Richard Van Noorden in Nature News.

Read the full article.